DCSCA Compliance Raises Concerns for 340B Covered Entities and Pharmacies
The Drug Supply Chain Security Act (DCSCA), a critical piece of legislation aimed at securing the pharmaceutical supply chain, has...
top of page
ACI 340B Management
Aug 29
ACI Monthly (August 2024)
August 2024 Volume 1, Issue 8 Inside this issue &J’s Proposed Rebate Program DCSCA Complications State bill updates AbbVie Restricts...
ACI 340B Management
Aug 20
AbbVie Ceases Offering 340B Pricing for Orphan Drugs for Certain Covered Entities
AbbVie, a global biopharmaceutical company, recently made headlines by ceasing to offer 340B ceiling prices effective August 1, 2024, for...
ACI 340B Management
Jun 24
ACI Monthly (June 2024)
June 2024 Volume 1, Issue 6 Inside this issue Sobi policy announcement Bausch & Lomb announcement Vertex announcement Other manufacturer...
ACI 340B Management
Jun 24
ACI Monthly (May 2024)
May 2024 Volume 1, Issue 5 Inside this issue Senate Proposal Current Status of State Bills to Protect Contract Pharmacy OPAIS...
ACI 340B Management
Jun 7
Enhancing Access and Care: The Role of 340B Covered Entities' Open Door Retail Pharmacies
In healthcare, accessibility, and affordability are pivotal pillars for ensuring that individuals receive the treatment and medications...
ACI 340B Management
May 16
Optimizing 340B Program Efficiency: Best Practices with TPAs and Manufacturer Blocks
The 340B Drug Pricing Program is crucial in expanding access to affordable medications for eligible healthcare organizations serving...
ACI 340B Management
Apr 22
ACI Monthly (April 2024)
April 2024 Volume 1, Issue 4 Inside this issue Recent Manufacturer Restriction Changes Senator Hints at Overhaul of the 340B Program...
ACI 340B Management
Apr 17
Recent Manufacturer Restriction Updates
As of April 1st, 2024, 32 drug manufacturers have implemented various contract pharmacy restrictions for Covered Entities within the 340B...
ACI 340B Management
Mar 18
Current 340B Legislation: Transforming Healthcare Access Nationwide
340B PATIENTS ACT Federal Legislation On March 12, 2024, legislators unveiled a new federal bill that addresses systemic barriers to...
ACI 340B Management
Mar 18
ACI Monthly (March 2024)
March 2024 Volume 1, Issue 3 Inside this issue 31st Drug Manufacturer 30th Drug Manufacturer SUSTAIN 340B Act Benefits of Contract...
ACI 340B Management
Mar 5
The Benefits of Multiple Contract Pharmacies in the 340B Program
The 340B Drug Pricing Program has been instrumental in ensuring access to affordable medications for vulnerable populations across the...
ACI 340B Management
Feb 23
Navigating the Healthcare Maze: Unpacking the Inflation Reduction Act’s Impact on 340B Savings and Operational Resilience
The Inflation Reduction Act, a legislative initiative aimed at curbing inflation, has sparked significant discourse within various...
ACI 340B Management
Feb 16
ACI Monthly (February 2024)
February 2024 Volume 1, Issue 2 Inside this issue Inflation Reduction Act State Policy Updates Consultant Benefits Special points of...
ACI 340B Management
Feb 15
ACI Monthly (January 2024)
January 2024 Volume 1, Issue 1 Inside this issue Biogen Update Takeda Update Gilead Update Manufacturer Restrictions & their Implications...
bottom of page